150 related articles for article (PubMed ID: 10572418)
1. [Present states of development in new drugs and treatment of inflammatory bowel disease].
Asakura H; Sugimura K
Nihon Rinsho; 1999 Nov; 57(11):2490-5. PubMed ID: 10572418
[TBL] [Abstract][Full Text] [Related]
2. Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease.
Nikolaus S; Fölscn U; Schreiber S
Hepatogastroenterology; 2000; 47(31):71-82. PubMed ID: 10690587
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy of IBD in 2009.
Harris A; Feller ER; Shah SA
Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
[No Abstract] [Full Text] [Related]
4. Managing the glucocorticoid dependent inflammatory bowel disease patient.
Bonner GF
Semin Gastrointest Dis; 2001 Oct; 12(4):237-44. PubMed ID: 11726077
[TBL] [Abstract][Full Text] [Related]
5. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
7. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
Hibi T; Inoue N; Ogata H; Naganuma M
J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
[TBL] [Abstract][Full Text] [Related]
8. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Kreisel W; Wolf LM; Grotz W; Grieshaber M
Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
Danese S
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S225-8. PubMed ID: 18598993
[TBL] [Abstract][Full Text] [Related]
10. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
Bauditz J; Lochs H; Schreiber S
N Engl J Med; 1998 Jan; 338(5):334. PubMed ID: 9446035
[No Abstract] [Full Text] [Related]
11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
12. [Chronic inflammatory bowel disease--pathogenic concepts and therapeutic perspectives].
Madsen JR
Ugeskr Laeger; 2000 Mar; 162(10):1361-6. PubMed ID: 10745672
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
Moffatt DC; Bernstein CN
Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
[TBL] [Abstract][Full Text] [Related]
14. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy.
van Hogezand RA; Verspaget HW
Scand J Gastroenterol Suppl; 1997; 223():105-7. PubMed ID: 9200315
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory peptides and proteins in inflammatory bowel disease.
Veljaca M
Curr Opin Investig Drugs; 2001 Oct; 2(10):1387-94. PubMed ID: 11890353
[TBL] [Abstract][Full Text] [Related]
16. [Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines].
Stange EF
Z Gastroenterol; 2002 Apr; 40 Suppl 1():S90-S1. PubMed ID: 11930299
[TBL] [Abstract][Full Text] [Related]
17. [Immune response to biological therapy of inflammatory bowel diseases].
Kniazev OV; Parfenov AI; Ruchkina IN; Lazebnik LB; Sagynbaeva VÉ
Ter Arkh; 2013; 85(12):55-9. PubMed ID: 24640669
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Sutherland LR
CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
[TBL] [Abstract][Full Text] [Related]
19. Pancreatitis in inflammatory bowel diseases.
Pitchumoni CS; Rubin A; Das K
J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic J; Segal I
Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
